NCT03633331 2021-10-15Palbociclib and Letrozole or Fulvestrant in Treating Patients With Estrogen Receptor Positive, HER2 Negative Metastatic Breast CancerAlliance for Clinical Trials in OncologyPhase 2 Unknown93 enrolled 8 charts